Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potential interaction between telithromycin and warfarin.

Likurgos Kolilekas1, George K Anagnostopoulos, Ioannis Lampaditis

  • 1Department of Pulmonary Medicine, Hellenic Air Force and Veterans General Hospital, Athens, Greece. lykol@yahoo.gr

The Annals of Pharmacotherapy
|July 29, 2004
PubMed
Summary

A case report highlights a significant drug interaction between warfarin and telithromycin, leading to elevated international normalized ratio (INR) and bleeding. Close monitoring of INR is crucial for patients on warfarin receiving telithromycin to prevent complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design, Rationale, Methodology, and Aims of a Greek Prospective Idiopathic Pulmonary Fibrosis Registry: Investigating Idiopathic Pulmonary Fibrosis in Greece (INDULGE IPF).

Respiration; international review of thoracic diseases·2018
Same author

High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations.

Cytokine·2017
Same author

The New Idiopathic Pulmonary Fibrosis Acute Exacerbations Document: One Step Ahead but Still Suspended in the Air.

American journal of respiratory and critical care medicine·2017
Same author

Combined pulmonary fibrosis and emphysema: The many aspects of a cohabitation contract.

Respiratory medicine·2016
Same author

Acute Respiratory Events in Connective Tissue Disorders.

Respiration; international review of thoracic diseases·2016
Same author

Survival in Idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach.

BMC pulmonary medicine·2015

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Drug Interactions

Background:

  • Warfarin is a common anticoagulant requiring regular monitoring of the international normalized ratio (INR).
  • Telithromycin, a ketolide antibiotic, is used for respiratory tract infections.
  • Drug interactions can alter the efficacy and safety of anticoagulant therapy.

Observation:

  • A 73-year-old male patient experienced elevated INR and hemoptysis while on warfarin therapy.
  • The patient was concurrently treated with telithromycin 800 mg/day.
  • INR levels rose from 3.1 to 11 within 5 days of telithromycin initiation.

Findings:

  • Discontinuation of telithromycin led to INR normalization within 4 days.
  • This interaction between warfarin and telithromycin has not been previously described.

Related Experiment Videos

  • The mechanism is suspected to involve inhibition of warfarin metabolism, possibly via CYP1A2 or CYP3A4 pathways.

    • Implications:

    • Healthcare providers should be aware of the potential for warfarin-telithromycin interactions.
    • Close INR monitoring is recommended for patients on warfarin who are prescribed telithromycin.
    • This case underscores the importance of vigilance in managing polypharmacy and preventing adverse drug events.